Real-time market analysis on the Russell indexes is available at http://www.russell.com/indexes/performance/real_time_market_analysis.asp, and a preliminary list of additions to the Russell Microcap(R) Index is currently posted on http://www.russell.com.
About Russell Investments
Russell Investments aims to improve financial security for people by providing strategic advice, world-class implementation, state-of-the-art performance benchmarks, and a range of institutional-quality investment products. With more than $200 billion in assets under management, Russell serves individual, institutional and advisor clients in more than 40 countries. Russell provides access to some of the world's best money managers. It helps investors put this access to work in corporate defined benefit and defined contribution plans, and in the life savings of individual investors. Russell's indexes are unmanaged and cannot be invested in directly. Headquartered in Tacoma, Washington, Russell has principal offices in Amsterdam, Auckland, Johannesburg, London, Melbourne, New York, Paris, San Francisco, Seoul, Singapore, Sydney, Tokyo and Toronto.
About The Female Health Company
The Female Health Company (FHC), headquartered in Chicago, IL, is the
maker of the FC Female Condom (FC1 and FC2), a revolutionary option
offering women dual protection against both sexually transmitted diseases,
including HIV/AIDS, and unintended pregnancy. FHC was created as a
worldwide company in February 1996 with the purchase of Chartex Resources
Ltd., the holder of exclusive worldwide rights to FC1. The Company holds
exclusive product and technology patents for FC1 in the United States,
Australia, Brazil, Canada, France, Germany, Italy, Spain, the United
Kingdom, the People's Republic of China, South Korea and Japan. Pate
|SOURCE The Female Health Company|
Copyright©2008 PR Newswire.
All rights reserved